{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:05:15Z","timestamp":1792001115462,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW106-TDU-B-212-113004"],"award-info":[{"award-number":["MOHW106-TDU-B-212-113004"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["No. DMR-107-211"],"award-info":[{"award-number":["No. DMR-107-211"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-0973-5","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T13:06:17Z","timestamp":1556370377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents"],"prefix":"10.1186","volume":"19","author":[{"given":"Wei-Fan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Pang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Heng","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Tarn","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6086","authenticated-orcid":false,"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,27]]},"reference":[{"key":"973_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018;69:461\u2013511.","journal-title":"J Hepatol"},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41598-017-03589-w","volume":"7","author":"HW Wang","year":"2017","unstructured":"Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, et al. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep. 2017;7:3259.","journal-title":"Sci Rep"},{"key":"973_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u201326.","journal-title":"Hepatology."},{"key":"973_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology."},{"key":"973_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/cid\/cit245","volume":"57","author":"SD Holmberg","year":"2013","unstructured":"Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, et al. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013;57:240\u20136.","journal-title":"Clin Infect Dis"},{"key":"973_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jvh.12224","volume":"21","author":"J Li","year":"2014","unstructured":"Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, et al. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014;21:930\u20137.","journal-title":"J Viral Hepat"},{"key":"973_CR7","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/hep.24641","volume":"54","author":"MG Ghany","year":"2011","unstructured":"Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. American Association for Study of liver D. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54:1433\u201344.","journal-title":"Hepatology."},{"key":"973_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12072-016-9717-6","volume":"10","author":"M Omata","year":"2016","unstructured":"Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatol Int. 2016;10:702\u201326.","journal-title":"Hepatol Int"},{"key":"973_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/gast.2002.33023","volume":"122","author":"T Poynard","year":"2002","unstructured":"Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002;122:1303\u201313.","journal-title":"Gastroenterology."},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/infdis\/jiu630","volume":"211","author":"CC Liang","year":"2015","unstructured":"Liang CC, Liu CH, Chung CS, Lin CK, Su TH, Yang HC, et al. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. J Infect Dis. 2015;211:1429\u201336.","journal-title":"J Infect Dis"},{"key":"973_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/gast.2002.34175","volume":"123","author":"M Peck-Radosavljevic","year":"2002","unstructured":"Peck-Radosavljevic M, Wichlas M, Homoncik-Kraml M, Kreil A, Hofer H, Jessner W, et al. Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. Gastroenterology. 2002;123:141\u201351.","journal-title":"Gastroenterology."},{"key":"973_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gut.2004.057893","volume":"54","author":"M Schmid","year":"2005","unstructured":"Schmid M, Kreil A, Jessner W, Homoncik M, Datz C, Gangl A, et al. Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens. Gut. 2005;54:1014\u201320.","journal-title":"Gut."},{"key":"973_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/jir.2017.0137","volume":"38","author":"M El-Raziky","year":"2018","unstructured":"El-Raziky M, Khairy M, Fouad A, Salama A, Elsharkawy A, Tantawy O. Effect of direct-acting agents on fibrosis regression in chronic hepatitis C virus Patients\u2019 treatment compared with interferon-containing regimens. J Interf Cytokine Res. 2018;38:129\u201336.","journal-title":"J Interf Cytokine Res"},{"key":"973_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-018-0486-5","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Chen L, Zhou Y. Changes of FibroScan, APRI, and FIB-4 in chronic hepatitis B patients with significant liver histological changes receiving 3-year entecavir therapy. Clin Exp Med. 2018;18:273\u201382.","journal-title":"Clin Exp Med"},{"key":"973_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim WR, Berg T, Asselah T, Flisiak R, Fung S, Gordon SC, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773\u201380.","journal-title":"J Hepatol"},{"key":"973_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","volume":"62","author":"Panel AIHG","year":"2015","unstructured":"Panel AIHG. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62:932\u201354.","journal-title":"Hepatology."},{"key":"973_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/liv.13256","volume":"37","author":"JA Bachofner","year":"2017","unstructured":"Bachofner JA, Valli PV, Kroger A, Bergamin I, Kunzler P, Baserga A, et al. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index. Liver Int. 2017;37:369\u201376.","journal-title":"Liver Int"},{"key":"973_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/MEG.0000000000000964","volume":"29","author":"E Dolmazashvili","year":"2017","unstructured":"Dolmazashvili E, Abutidze A, Chkhartishvili N, Karchava M, Sharvadze L, Tsertsvadze T. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience. Eur J Gastroenterol Hepatol. 2017;29:1223\u201330.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"973_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10620-017-4749-x","volume":"63","author":"J Chan","year":"2018","unstructured":"Chan J, Gogela N, Zheng H, Lammert S, Ajayi T, Fricker Z, et al. Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 months post-treatment. Dig Dis Sci. 2018;63:486\u201392.","journal-title":"Dig Dis Sci"},{"key":"973_CR20","doi-asserted-by":"publisher","first-page":"e4736","DOI":"10.1097\/MD.0000000000004736","volume":"95","author":"SH Chen","year":"2016","unstructured":"Chen SH, Peng CY, Chiang IP, Lai HC, Lee CJ, Su WP, et al. Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C. Medicine (Baltimore). 2016;95:e4736.","journal-title":"Medicine (Baltimore)"},{"key":"973_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/17474124.2017.1326816","volume":"11","author":"A Elsharkawy","year":"2017","unstructured":"Elsharkawy A, Eletreby R, Fouad R, Soliman Z, Abdallah M, Negm M, et al. Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients. Expert Rev Gastroenterol Hepatol. 2017;11:773\u20138.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"973_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11894-016-0508-y","volume":"18","author":"HC Gonzalez","year":"2016","unstructured":"Gonzalez HC, Duarte-Rojo A. Virologic cure of hepatitis C: impact on hepatic fibrosis and patient outcomes. Curr Gastroenterol Rep. 2016;18:32.","journal-title":"Curr Gastroenterol Rep"},{"key":"973_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","volume":"59","author":"T Poynard","year":"2013","unstructured":"Poynard T, Moussalli J, Munteanu M, Thabut D, Lebray P, Rudler M, et al. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. J Hepatol. 2013;59:675\u201383.","journal-title":"J Hepatol"},{"key":"973_CR24","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.20537","volume":"101","author":"A Makiyama","year":"2004","unstructured":"Makiyama A, Itoh Y, Kasahara A, Imai Y, Kawata S, Yoshioka K, et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer. 2004;101:1616\u201322.","journal-title":"Cancer."},{"key":"973_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11152\/mu-942","volume":"19","author":"X Hu","year":"2017","unstructured":"Hu X, Qiu L, Liu D, Qian L. Acoustic radiation force impulse (ARFI) Elastography for noninvasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis. Med Ultrason. 2017;19:23\u201331.","journal-title":"Med Ultrason"},{"key":"973_CR26","doi-asserted-by":"publisher","first-page":"e0190455","DOI":"10.1371\/journal.pone.0190455","volume":"13","author":"SH Chen","year":"2018","unstructured":"Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, et al. Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. PLoS One. 2018;13:e0190455.","journal-title":"PLoS One"},{"key":"973_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-230X-12-105","volume":"12","author":"SH Chen","year":"2012","unstructured":"Chen SH, Li YF, Lai HC, Kao JT, Peng CY, Chuang PH, et al. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. BMC Gastroenterol. 2012;12:105.","journal-title":"BMC Gastroenterol"},{"key":"973_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/liv.13486","volume":"38","author":"Y Tachi","year":"2018","unstructured":"Tachi Y, Hirai T, Kojima Y, Ishizu Y, Honda T, Kuzuya T, et al. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response. Liver Int. 2018;38:59\u201367.","journal-title":"Liver Int"},{"key":"973_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/gut.2008.149708","volume":"57","author":"U Arena","year":"2008","unstructured":"Arena U, Vizzutti F, Abraldes JG, Corti G, Stasi C, Moscarella S, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut. 2008;57:1288\u201393.","journal-title":"Gut."},{"key":"973_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cgh.2017.04.038","volume":"16","author":"S Singh","year":"2018","unstructured":"Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:27\u201338 e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"973_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MEG.0000000000000789","volume":"29","author":"S Tanwar","year":"2017","unstructured":"Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S, et al. Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. Eur J Gastroenterol Hepatol. 2017;29:289\u201396.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"973_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10620-006-9144-y","volume":"52","author":"Z Karasu","year":"2007","unstructured":"Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, et al. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52:1535\u20139.","journal-title":"Dig Dis Sci"},{"key":"973_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1056\/NEJM199809103391107","volume":"339","author":"K Kaushansky","year":"1998","unstructured":"Kaushansky K. Thrombopoietin. N Engl J Med. 1998;339:746\u201354.","journal-title":"N Engl J Med"},{"key":"973_CR34","doi-asserted-by":"publisher","first-page":"G469","DOI":"10.1152\/ajpgi.00407.2012","volume":"304","author":"PF Lalor","year":"2013","unstructured":"Lalor PF, Herbert J, Bicknell R, Adams DH. Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment. Am J Physiol Gastrointest Liver Physiol. 2013;304:G469\u201378.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"973_CR35","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/hep.28526","volume":"64","author":"A Chauhan","year":"2016","unstructured":"Chauhan A, Adams DH, Watson SP, Lalor PF. Platelets: no longer bystanders in liver disease. Hepatology. 2016;64:1774\u201384.","journal-title":"Hepatology."},{"key":"973_CR36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/jhep.2002.32486","volume":"35","author":"MB Streiff","year":"2002","unstructured":"Streiff MB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology. 2002;35:947\u201352.","journal-title":"Hepatology."},{"key":"973_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/apt.13343","volume":"42","author":"K Deterding","year":"2015","unstructured":"Deterding K, Honer Zu Siederdissen C, Port K, Solbach P, Sollik L, Kirschner J, et al. Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies. Aliment Pharmacol Ther. 2015;42:889\u2013901.","journal-title":"Aliment Pharmacol Ther"},{"key":"973_CR38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1756283X17715198","volume":"10","author":"M Pons","year":"2017","unstructured":"Pons M, Santos B, Simon-Talero M, Ventura-Cots M, Riveiro-Barciela M, Esteban R, et al. Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals. Ther Adv Gastroenterol. 2017;10:619\u201329.","journal-title":"Ther Adv Gastroenterol"},{"key":"973_CR39","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1111\/j.1572-0241.2003.08665.x","volume":"98","author":"E Giannini","year":"2003","unstructured":"Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E, et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol. 2003;98:2516\u201320.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0973-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-0973-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0973-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T19:08:24Z","timestamp":1587841704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-0973-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-0973-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735628255.793560026","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,27]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the 1975 Declaration of Helsinki. All patients provided written informed consent prior to enrollment, and this study was approved by the Research Ethics Committee of China Medical University Hospital, Taichung, Taiwan (CMUH106-REC2\u2013105).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Cheng-Yuan Peng has served as an advisory committee member for AbbVie, Bristol-Myers Squibb, Gilead, and Merck Sharp & Dohme. All other coauthors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}